Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 101–200 of 999
Long-term outcome among men with conservatively treated localised prostate cancer
on behalf of the Transatlantic Prostate Group, Cuzick, J. M., Fisher, G., Kattan, M. W., Berney, D. M., Oliver, R. T. D., Foster, C. S., Møller, H., Reuter, V., Fearn, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603411 · Cited by 134
Prostate-Specific Antigen Levels as a Predictor of Lethal Prostate Cancer
Fall, K., Garmo, H., Andrén, O., Bill‐Axelson, A., Adolfsson, J., Adami, H., Johansson, J.-E., & Holmberg, L. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk110 · Cited by 133
Self-citationAlbertsen, P. C., Hanley, J. A., Penson, D. F., Barrows, G. H., & Fine, J. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.10.051 · Cited by 132
Mucci, L. A., Powolny, A. A., Giovannucci, E. L., Liao, Z., Kenfield, S. A., Shen, R. Z., Stampfer, M. J., & Clinton, S. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8876 · Cited by 130
Patel, V., Coelho, R. F., Chauhan, S., Orvieto, M. A., Palmer, K. J., Rocco, B. M. C., Sivaraman, A., & Coughlin, G. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09541.x · Cited by 132
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series
Ahmed, H. U., Zacharakis, E., Dudderidge, T. J., Armitage, J. N., Scott, R., Calleary, J. G., Illing, R. O., Kirkham, A. P. S., Freeman, A., Ogden, C., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605116 · Cited by 129
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, O. A., Stanford, J. L., Zietman, A. L., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.014 · Cited by 129
Clarke, M., Hopewell, S., & Chalmers, L. (2007) · Journal of the Royal Society of Medicine · doi:10.1177/014107680710011415 · Cited by 129
Vickers, A. J., Till, C., Tangen, C. M., Lilja, H. G., & Thompson, I. M. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr028 · Cited by 128
Current Status of HIFU and Cryotherapy in Prostate Cancer – A Review
Aus, G. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.011 · Cited by 128
Bartsch, G. C., Horninger, W., Klocker, H., Pelzer, A. E., Bektić, J., Oberaigner, W., Schennach, H., Schäfer, G., Frauscher, F., Boniol, M., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07502.x · Cited by 141
ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling
Pai, V. C., Hsu, C., Chan, T., Liao, W., Chuu, C., Chen, W., Li, C., Lin, C., Huang, S., Chen, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0497-4 · Cited by 149
Screening for Prostate Cancer in U.S. Men
Lim, L. S., & Sherin, K. M. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.10.003 · Cited by 126
Ramsay, C. R., Adewuyi, T. E., Gray, J., Hislop, J., Shirley, M., Jayakody, S., MacLennan, G., Fraser, C. M., MacLennan, S. J., Brazzelli, M. G., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19490 · Cited by 141
Lantz, A. W., Bock, D., Akre, O., Angenete, E., Bjartell, A. S., Carlsson, S., Modig, K. K., Nyberg, M., Kollberg, K. S., Steineck, G., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.07.025 · Cited by 124
Pickles, T., Ruether, J. D., Weir, L. M., Carlson, L. E., Jakulj, F., & the SCRN Communication Team (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06981.x · Cited by 138
Recommandations en Onco-Urologie 2010 : Cancer de la prostate
Salomon, L., Azria, D., Bastide, C., Beuzeboc, P., Cormier, L., Cornud, F., Eiss, D., Eschwège, P., Gaschignard, N., Hennequin, C., et al. (2010) · The French Journal of Urology · doi:10.1016/s1166-7087(10)70042-7 · Cited by 149
Brachytherapy: Where Has It Gone?
Petereit, D. G., Frank, S. J., Viswanathan, A. N., Erickson, B. A., Eifel, P. J., Nguyen, P. L., & Wazer, D. E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.8128 · Cited by 121
Vickers, A. J., Savage, C. J., Bianco, F. J., Mulhall, J. P., Sandhu, J. S., Guillonneau, B. D., Cronin, A. M., & Scardino, P. T. (2010) · European Urology · doi:10.1016/j.eururo.2010.10.045 · Cited by 127
Warmuth, M., Johansson, T., & Mad, P. (2010) · European Urology · doi:10.1016/j.eururo.2010.09.009 · Cited by 120
The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer
Lindberg, J., Mills, I. G., Klevebring, D., Liu, W., Neiman, M., Xu, J., Wikström, P., Wiklund, P. N., Wiklund, F. E., Egevad, L., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.11.053 · Cited by 133
Active surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L. H. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.002 · Cited by 134
Herbst, R. S., Bajorin, D. F., Bleiberg, H., Blum, D., Hao, D., Johnson, B. E., Ozols, R. F., Demetri, G. D., Ganz, P. A., Kris, M. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8678 · Cited by 119
Brown, L. C., Ahmed, H. U., Faria, R., Bosaily, A. E., Gabe, R., Kaplan, R. S., Parmar, M., Collaço‐Moraes, Y., Ward, K., Hindley, R. G., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22390 · Cited by 118
Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study
Siddiqui, S. A., Inman, B. A., Sengupta, S., Slezak, J. M., Bergstralh, E. J., Leibovich, B. C., Zincke, H., & Blute, M. L. (2006) · Cancer · doi:10.1002/cncr.22030 · Cited by 118
Shields, A. F. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0039-2 · Cited by 114
Davison, B. J., & Breckon, E. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.11.009 · Cited by 115
Tewari, A. K., Divine, G., Chang, P., Shemtov, M. M., Milowsky, M. I., Nanus, D. M., & Menon, M. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.10.040 · Cited by 115
Stephenson, A. J., Bolla, M., Briganti, A., Cozzarini, C., Moul, J. W., Roach, M., van Poppel, H., & Zietman, A. L. (2011) · European Urology · doi:10.1016/j.eururo.2011.10.010 · Cited by 115
Prostate Cancer: Current Treatment and Prevention Strategies
Chen, F., & Zhao, X. (2013) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.6499 · Cited by 120
Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging Agent
Kelly, K. A., Setlur, S. R., Ross, R. W., Anbazhagan, R., Waterman, P. R., Rubin, M. A., & Weissleder, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1349 · Cited by 111
Forget, P., TOMBAL, B. F., Scholtès, J.-L., Nzimbala, J., Meulders, C., Legrand, C., Cangh, P. V., Cosyns, J., & Kock, M. D. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32834b7d9a · Cited by 110
Robotic‐assisted radical prostatectomy: a review of current outcomes
Coelho, R. F., Chauhan, S., Palmer, K. J., Rocco, B. M. C., Patel, M. B., & Patel, V. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08895.x · Cited by 109
Bittencourt, L. K., Barentsz, J. O., de Miranda, L. C. D., & Gasparetto, E. L. (2011) · European Radiology · doi:10.1007/s00330-011-2269-1 · Cited by 115
Kendal, W. S. (2008) · Cancer · doi:10.1002/cncr.23315 · Cited by 108
Ilić, D., O’Connor, D. A., Green, S., & Wilt, T. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub2 · Cited by 131
Keshari, K. R., Sriram, R., Van Criekinge, M., Wilson, D. M., Wang, Z. J., Vigneron, D. B., Peehl, D. M., & Kurhanewicz, J. (2013) · The Prostate · doi:10.1002/pros.22665 · Cited by 105
Johansson, E., Bill‐Axelson, A., Holmberg, L., Onelöv, E., Johansson, J., & Steineck, G. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.054 · Cited by 104
Self-citationComorbidity and competing risks for mortality in men with prostate cancer
Daskivich, T. J., Chamie, K., Kwan, L. C., Labo, J., Dash, A., Greenfield, S., & Litwin, M. S. (2011) · Cancer · doi:10.1002/cncr.26104 · Cited by 111
Nelson, C. J., Scardino, P. T., Eastham, J. A., & Mulhall, J. P. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12135 · Cited by 101
Etzioni, R., Gulati, R., Falcon, S., & Penson, D. F. (2008) · Medical Decision Making · doi:10.1177/0272989x07312719 · Cited by 105
Choi, J. M., Nelson, C. J., Stasi, J. P., & Mulhall, J. P. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.150 · Cited by 105
Nam, R. K., Herschorn, S., Loblaw, D. A., Liu, Y., Klotz, L. H., Carr, L. K., Kodama, R. T., Stanimirovic, A., Venkateswaran, V., Saskin, R., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.005 · Cited by 100
Shappley, W. V., Kenfield, S. A., Kasperzyk, J. L., Qiu, W., Stampfer, M. J., Sanda, M. G., & Chan, J. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2613 · Cited by 100
Erectile dysfunction following prostatectomy: prevention and treatment
Magheli, A., & Burnett, A. L. “. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.126 · Cited by 107
Singh, S., Singh, R., Sharma, P., Singh, U. P., Rai, S. N., Chung, L. W. K., Cooper, C. R., Novakovic, K. R., Grizzle, W. E., & Lillard, J. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.022 · Cited by 99
Impact of Positive Surgical Margins After Radical Prostatectomy Differs by Disease Risk Group
Alkhateeb, S., Alibhai, S. M. H., Fleshner, N. E., Finelli, A., Jewett, M. A. S., Zlotta, A. R., Nesbitt, M. E., Lockwood, G. A., & Trachtenberg, J. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.132 · Cited by 97
Oliffe, J. L., Davison, B. J., Pickles, T., & Mróz, L. (2009) · Qualitative Health Research · doi:10.1177/1049732309332692 · Cited by 110
Heidenreich, A., Joaquim Bellmunt, B., Bolla, M., Joniau, S., Mason, M. D., Matveev, V. B., Mottet, N., Schmid, H., van der Kwast, T., Wiegel, T., et al. (2011) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2011.04.004 · Cited by 98
Can clinically localized prostate cancer be managed conservatively?
Klotz, L. H. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0292 · Cited by 98
Cussenot, O., Azzouzi, A.-R., Nicolaı̈ew, N., Fromont, G., Mangin, P., Cormier, L., Fournier, G., Valéri, A., Larré, S., Thibault, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0908 · Cited by 97
Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate
Salomon, L., Bastide, C., Beuzeboc, P., Cormier, L., Fromont, G., Hennequin, C., Mongiat-Artus, P., Peyromaure, M., Ploussard, G., Renard‐Penna, R., et al. (2013) · The French Journal of Urology · doi:10.1016/s1166-7087(13)70048-4 · Cited by 113
High Dose Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer
Rogers, L., Alder, S. C., Rogers, R., Hopkins, S. A., Platt, M. L., Childs, L., Crouch, R. H., Hansen, R. S., & Hayes, J. K. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.09.050 · Cited by 95
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer
Wolff, R. F., Ryder, S., Bossi, A., Briganti, A., Crook, J. M., Henry, A. M., Karnes, J. R., Potters, L., de Reijke, T. M., Stone, N. N., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.019 · Cited by 110
Internet Health Resources and the Cancer Patient
Huang, G. J., & Penson, D. F. (2008) · Cancer Investigation · doi:10.1080/07357900701566197 · Cited by 95
Ahmed, H. U., Moore, C. M., & Emberton, M. (2009) · Surgical Oncology · doi:10.1016/j.suronc.2009.02.002 · Cited by 94
Hendrik Isbarn, A., Wanner, M., Salomon, G., Steuber, T. P., Schlomm, T., Köllermann, J. W., Sauter, G., Haese, A., Hans Heinzer, A., Huland, H., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.09134.x · Cited by 94
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer
Bratt, O., Folkvaljon, Y., Eriksson, M. H., Akre, O., Carlsson, S., Drevin, L., Lissbrant, I. F., Makarov, D. V., Loeb, S., & Stattin, P. E. (2015) · European Urology · doi:10.1016/j.eururo.2014.12.026 · Cited by 101
Kendal, W. S., Eapen, L. J., MacRae, R. M., Malone, S. C., & Nicholas, G. A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.013 · Cited by 93
Evidence to Support a Continued Stage Migration and Decrease in Prostate Cancer Specific Mortality
Galper, S. L., Chen, M., Catàlona, W. J., Roehl, K. A., Richie, J. P., & D'Amico, A. V. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00419-2 · Cited by 99
Granfors, T., Modig, H. G., Damber, J., & Tomić, R. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.03.092 · Cited by 90
EZH2, Ki‐67 and MCM7 are prognostic markers in prostatectomy treated patients
Laitinen, S., MARTIKAINEN, P. M., Tolonen, T. T., Isola, J. J., Tammela, T. L. J., & Visakorpi, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.23145 · Cited by 90
Trends in the treatment of localized prostate cancer using supplemented cancer registry data
Hamilton, A. S., Albertsen, P. C., Johnson, T. K., Hoffman, R. M., Morrell, D., Deapen, D., & Penson, D. F. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09514.x · Cited by 89
Stranne, J., Johansson, E., Nilsson, A. E., Bill‐Axelson, A., Carlsson, S., Holmberg, L., Johansson, J., Nyberg, T., Ruutu, M. L., Wiklund, P. N., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.08.006 · Cited by 89
Self-citationCurrent Prostate Cancer Treatments: Effect on Quality of Life
Gomella, L. G., Johannes, J. R., & Trabulsi, E. J. (2009) · Urology · doi:10.1016/j.urology.2009.03.003 · Cited by 92
Atkins, D. C., Chang, S., Gartlehner, G., Buckley, D., Whitlock, E. P., Berliner, E., & Matchar, D. B. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.11.021 · Cited by 104
COBELLI, F. D., Ravelli, S., Esposito, A., Giganti, F., Andrea Gallina, A., Montorsi, F., & Maschio, A. D. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.13146 · Cited by 86
Chun, F. K. ‐., Briganti, A., Claudio Jeldres, A., Andrea Gallina, A., Erbersdobler, A., Schlomm, T., Walz, J. C., Eichelberg, C., Salomon, G., Haese, A., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.018 · Cited by 86
Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men
Loeb, S., Roehl, K. A., Catàlona, W. J., & Nadler, R. B. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.10.028 · Cited by 86
Konety, B. R., Cowan, J. E., Carroll, P. R., & CaPSURE Investigators (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.044 · Cited by 86
Prostate Cancer: Multiparametric MRI for Index Lesion Localization—A Multiple-Reader Study
Rosenkrantz, A. B., Deng, F.-M., Kim, S., Lim, R., Hindman, N. M., Mussi, T. C., Spieler, B. M., Oaks, J., Babb, J. S., Melamed, J., et al. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8446 · Cited by 85
Kundra, V., Silverman, P. M., Matin, S. F., & Choi, H. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2011 · Cited by 84
Androgen deprivation therapy for prostate cancer
Singer, E. A., Golijanin, D. J., Miyamoto, H., & Messing, E. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.211 · Cited by 95
Active Surveillance for Prostate Cancer: A Review
Klotz, L. H. (2010) · Current Urology Reports · doi:10.1007/s11934-010-0110-z · Cited by 82
Gleason score, age and screening: Modeling dedifferentiation in prostate cancer
Draisma, G., Postma, R., Schröder, F. H., van der Kwast, T., & de Koning, H. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22158 · Cited by 97
Penson, D. F., Chan, J. M., & Urologic Diseases in America Project (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.121 · Cited by 81
Shore, N. D., Kella, N., Moran, B. J., Boczko, J., Bianco, F. J., Crawford, E. D., Davis, T., Roundy, K. M., Rushton, K., Grier, C. E., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.09.072 · Cited by 81
Fracalanza, S., Ficarra, V., Cavalleri, S., Antonio Galfano, A., Novara, G., Mangano, A., Plebani, M., & Artibani, W. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07513.x · Cited by 80
Screening for Prostate Cancer: An Update
Bryant, R. J., & Hamdy, F. C. (2007) · European Urology · doi:10.1016/j.eururo.2007.08.034 · Cited by 79
Barreto-Andrade, J. C., Efimova, E. V., Mauceri, H. J., Beckett, M. A., Sutton, H. G., Darga, T. E., Vokes, E. E., Posner, M. C., Kron, S. J., & Weichselbaum, R. R. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0061 · Cited by 87
Dickinson, L., Ahmed, H. U., Kirkham, A. P. S., ALLEN, C. M., Freeman, A., Barber, J., Hindley, R. G., Leslie, T. A., Ogden, C., Persad, R. A., et al. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.06.005 · Cited by 80
Schymura, M. J., Kahn, A. R., German, R. R., Hsieh, M., Cress, R. D., Finch, J. L., Fulton, J. P., Shen, T., & Stuckart, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-152 · Cited by 80
Drouin, S., Vaessen, C., Hupertan, V., Compérat, É., Misraï, V., Haertig, A., Bitker, M., Chartier-Kastler, E. J., Richard, F., & Morgan Rouprêt, A. (2009) · World Journal of Urology · doi:10.1007/s00345-009-0379-z · Cited by 80
Beuzeboc, P., Cornud, F., Eschwège, P., Gaschignard, N., Grosclaude, P., Hennequin, C., Maingon, P., Molinié, V., Mongiat-Artus, P., Moreau, J.-L., et al. (2007) · The French Journal of Urology · doi:10.1016/s1166-7087(07)74785-1 · Cited by 86
Agarwal, C., Ravikanth, V., Kaur, M., Chou, S., Thompson, J. A., & Agarwal, R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm045 · Cited by 80
Moore, A. L., Dimitropoulou, P., Lane, J. A., Powell, P. H., Greenberg, D. C., Brown, C. H., Donovan, J., Hamdy, F. C., Martin, R. M., & Neal, D. E. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08652.x · Cited by 85
Molecular markers of prostate cancer
Bradford, T. J., Tomlins, S. A., Wang, X., & Chinnaiyan, A. M. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.07.004 · Cited by 90
Sommers, B. D., Beard, C. J., D'Amico, A. V., Dahl, D. M., Kaplan, I. D., Richie, J. P., & Zeckhauser, R. (2007) · Cancer · doi:10.1002/cncr.23028 · Cited by 80
Prostate cancer prevention: Past, present, and future
Fleshner, N. E., & Zlotta, A. R. (2007) · Cancer · doi:10.1002/cncr.23009 · Cited by 89
D'Amico, A. V., Moran, B. J., Braccioforte, M. H., Dosoretz, D. E., Salenius, S. A., Katin, M. J., Ross, R., & Chen, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3992 · Cited by 77
Disease-specific survival following the brachytherapy management of prostate cancer
Stock, R. G., Cesaretti, J. A., & Stone, N. N. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.09.005 · Cited by 78
Tollefson, M. K., Karnes, R. J., Kwon, E. D., Lohse, C. M., Rangel, L. J., Mynderse, L. A., Cheville, J. C., & Sebo, T. J. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.12.001 · Cited by 83
Delay of Surgery in Men With Low Risk Prostate Cancer
O’Brien, D. R., Loeb, S., Carvalhal, G. F., McGuire, B. B., Kan, D., Hofer, M. D., Casey, J. T., Helfand, B. T., & Catàlona, W. J. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.02.009 · Cited by 78
Schröder, F. H. (2008) · European Urology · doi:10.1016/j.eururo.2008.01.049 · Cited by 92
Roemeling, S., Roobol, M. J., Postma, R., Gosselaar, C., van der Kwast, T., Bangma, C. H., & Schröder, F. H. (2006) · European Urology · doi:10.1016/j.eururo.2006.04.019 · Cited by 77
Variations in Quality of Care for Men With Early-Stage Prostate Cancer
Spencer, B. A., Miller, D. C., Litwin, M. S., Ritchey, J. D., Stewart, A. K., Dunn, R. L., Gay, E. G., Sandler, H. M., & Wei, J. T. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2555 · Cited by 78
Suzuki, H., Komiya, A., Kamiya, N., Imamoto, T., Kawamura, K., Miura, J., Suzuki, N., Nakatsu, H., Hata, A., & Ichikawa, T. (2006) · Urology · doi:10.1016/j.urology.2005.07.040 · Cited by 76
Elasticity as a biomarker for prostate cancer: a systematic review
Good, D. W., Stewart, G. D., Hammer, S. J., Scanlan, P., Shu, W., Phipps, S., Reuben, R. L., & McNeill, A. S. (2013) · British Journal of Urology · doi:10.1111/bju.12236 · Cited by 75
Current status of robot-assisted surgery
Ng, A. T. L., & Tam, P. (2014) · Hong Kong Medical Journal · doi:10.12809/hkmj134167 · Cited by 74
Taylor, K. L., Luta, G., Miller, A. B., Church, T. R., Kelly, S. P., Muenz, L. R., Davis, K. M., Dawson, D. L., Edmond, S. N., Reding, D. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.2767 · Cited by 78
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.